Skip to content

Effect of Neoadjuvant Therapy on Perioperative Neurocognitive Function in Breast Cancer Patients: A Prospective Cohort Stud

Effect of Neoadjuvant Therapy on Perioperative Neurocognitive Function in Breast Cancer Patients: A Prospective Cohort Stud

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123305
Enrollment
Unknown
Registered
2026-04-23
Start date
2026-04-30
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Group receiving neoadjuvant therapy prior to surgery:None
Group that did not receive neoadjuvant therapy prior to surgery:None

Sponsors

Affiliated Hospital of Guizhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. ASA classification =18 years; 3. Pathological diagnosis of breast cancer; 4. No severe visual or hearing impairments and able to read, capable of understanding and cooperating with neuropsychological tests; 5. Planned elective or limited-time breast cancer surgery under general anesthesia, with an expected surgery duration >=60 minutes; 6. Expected postoperative hospital stay of at least 3 days; 7. Patient voluntarily participates and signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients with intracranial abnormalities (central nervous system-related diseases) detected by cranial CT or MRI examination; 2.Patients with severe systemic diseases prior to surgery (e.g., respiratory system, circulatory system, severe liver or kidney dysfunction, etc.); 3.Patients with a history of psychiatric symptoms or diseases that preclude cooperation with cognitive assessment, or patients with dependence on psychotropic substances; 4.Patients with a history of alcohol or drug abuse.

Design outcomes

Primary

MeasureTime frame
Cognitive function 3 months post-surgery;

Secondary

MeasureTime frame
IL-6;IL-8;TNF-a;

Countries

China

Contacts

Public ContactXiaohua Zou

Affiliated Hospital of Guizhou Medical University

zouxiaohuazxh@163.com+86 138 0941 6036

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026